These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 7606790)

  • 21. Tyrosine kinase-dependent activation of human NK cell functions upon stimulation through a 58-kDa surface antigen selectively expressed on discrete subsets of NK cells and T lymphocytes.
    Melero I; Salmerón A; Balboa MA; Aramburu J; López-Botet M
    J Immunol; 1994 Feb; 152(4):1662-73. PubMed ID: 8120376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen.
    Pérez-Villar JJ; Melero I; Rodríguez A; Carretero M; Aramburu J; Sivori S; Orengo AM; Moretta A; López-Botet M
    J Immunol; 1995 Jun; 154(11):5779-88. PubMed ID: 7751628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GP120 specific cellular cytotoxicity in HIV-1 seropositive individuals. Evidence for circulating CD16+ effector cells armed in vivo with cytophilic antibody.
    Tyler DS; Nastala CL; Stanley SD; Matthews TJ; Lyerly HK; Bolognesi DP; Weinhold KJ
    J Immunol; 1989 Feb; 142(4):1177-82. PubMed ID: 2536767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulation of tyrosine phosphorylation and calcium mobilization by Fc gamma receptor cross-linking. Regulation by the phosphotyrosine phosphatase CD45.
    Rankin BM; Yocum SA; Mittler RS; Kiener PA
    J Immunol; 1993 Jan; 150(2):605-16. PubMed ID: 8419492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-Gal IgG potentiates natural killer cell migration across porcine endothelium via endothelial cell activation and increased natural killer cell motility triggered by CD16 cross-linking.
    Hauzenberger E; Klominek J; Holgersson J
    Eur J Immunol; 2004 Apr; 34(4):1154-63. PubMed ID: 15048727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD45 molecule cross-linking inhibits natural killer cell-mediated lysis independently of lytic triggering.
    Starling GC; Hart DN
    Immunology; 1990 Oct; 71(2):190-5. PubMed ID: 2146214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-linking of alpha 4 beta 1 and alpha 5 beta 1 fibronectin receptors enhances natural killer cell cytotoxic activity.
    Palmieri G; Serra A; De Maria R; Gismondi A; Milella M; Piccoli M; Frati L; Santoni A
    J Immunol; 1995 Dec; 155(11):5314-22. PubMed ID: 7594545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of monomeric human IgG defines an expression polymorphism of Fc gamma RIII on large granular lymphocyte/natural killer cells.
    Vance BA; Huizinga TW; Wardwell K; Guyre PM
    J Immunol; 1993 Dec; 151(11):6429-39. PubMed ID: 8245476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of natural killer cells via the Fc gamma RIII (CD16) requires initial tyrosine phosphorylation.
    Ståhls A; Heiskala M; Mustelin T; Andersson LC
    Eur J Immunol; 1992 Feb; 22(2):611-4. PubMed ID: 1371474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the Fc mu receptor on human natural killer cells. Interaction with its physiologic ligand, human normal IgM, specificity of binding, and functional effects.
    Pricop L; Rabinowich H; Morel PA; Sulica A; Whiteside TL; Herberman RB
    J Immunol; 1993 Sep; 151(6):3018-29. PubMed ID: 7690792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulation of IL-2-activated natural killer cells through the Kp43 surface antigen up-regulates TNF-alpha production involving the LFA-1 integrin.
    Aramburu J; Balboa MA; Rodríguez A; Melero I; Alonso M; Alonso JL; López-Botet M
    J Immunol; 1993 Oct; 151(7):3420-9. PubMed ID: 8104219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Receptors for the Fc fragment of IgG on natural killer cells.
    Trinchieri G; Valiante N
    Nat Immun; 1993; 12(4-5):218-34. PubMed ID: 8257828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell type-specific glycoforms of Fc gamma RIIIa (CD16): differential ligand binding.
    Edberg JC; Kimberly RP
    J Immunol; 1997 Oct; 159(8):3849-57. PubMed ID: 9378972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human monocytes CD36 and CD16 are signaling molecules. Evidence from studies using antibody-induced chemiluminescence as a tool to probe signal transduction.
    Trezzini C; Jungi TW; Spycher MO; Maly FE; Rao P
    Immunology; 1990 Sep; 71(1):29-37. PubMed ID: 1698715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monomeric IgG2 enhances Ig production and proliferation in human B cells.
    Kimata H; Yoshida A; Ishioka C; Jiang Y; Kusunoki T; Mikawa H
    Biotechnol Ther; 1993; 4(1-2):1-16. PubMed ID: 8374507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Agonistic effects of anti-CD2 and anti-CD16 antibodies on human natural killer killing.
    Uggla CK; Geisberg M; Jondal M; Knowles RW
    Scand J Immunol; 1989 May; 29(5):507-15. PubMed ID: 2567053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fc gamma RIIIA-mediated signaling involves src-family lck in human natural killer cells.
    Pignata C; Prasad KV; Robertson MJ; Levine H; Rudd CE; Ritz J
    J Immunol; 1993 Dec; 151(12):6794-800. PubMed ID: 8258691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a human natural killer cell target cell antigen with monoclonal antibodies.
    Harris DT; Jaso-Friedmann L; Devlin RB; Koren HS; Evans DL
    J Immunol; 1989 Jul; 143(2):727-35. PubMed ID: 2738407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on the concentration-effect relationship.
    Dall'Ozzo S; Tartas S; Paintaud G; Cartron G; Colombat P; Bardos P; Watier H; Thibault G
    Cancer Res; 2004 Jul; 64(13):4664-9. PubMed ID: 15231679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of human natural killer cell activity by cytophilic immunoglobulin G.
    Sulica A; Gherman M; Galatiuc C; Manciulea M; Herberman RB
    J Immunol; 1982 Mar; 128(3):1031-6. PubMed ID: 7057031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.